COSCIENS Biopharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,871 | $2,337 | $2,052 | $1,389 |
Gross Profit | 957 | 819 | 901 | 218 |
Net Income | -5,755 | -1,422 | -1,398 | -1,652 |
Net Change In Cash | 1,871 | 2,337 | 2,052 | 1,389 |
Free Cash Flow | -7,910 | -1,546 | -3,999 | -2,331 |
Cash | 19,998 | 27,804 | 3,513 | 6,666 |
Basic Shares | 3,121 | 3,061 | 1,847 | 1,847 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $7,261 | $13,881 | $13,486 | $11,858 |
Gross Profit | 2,982 | 8,117 | 8,209 | 5,977 |
Net Income | -3,550 | 3,240 | 2,639 | 1,455 |
Net Change In Cash | 7,261 | 13,881 | 13,486 | 11,858 |
Free Cash Flow | -3,470 | 6,247 | 2,801 | 3,833 |
Cash | 8,843 | 13,810 | 7,780 | 5,369 |
Basic Shares | 78,293 | 78,233 | 77,685 | 77,621 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.85 |
2024-06-30 | -$0.64 |
2024-03-31 | -$18.95 |
2023-12-31 | -$4.64 |
